These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8779715)

  • 1. Off-the-shelf proteins that rival tailor-made antibodies as catalysts.
    Hollfelder F; Kirby AJ; Tawfik DS
    Nature; 1996 Sep; 383(6595):60-2. PubMed ID: 8779715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large rate accelerations in antibody catalysis by strategic use of haptenic charge.
    Thorn SN; Daniels RG; Auditor MT; Hilvert D
    Nature; 1995 Jan; 373(6511):228-30. PubMed ID: 7816136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonspecific medium effects versus specific group positioning in the antibody and albumin catalysis of the base-promoted ring-opening reactions of benzisoxazoles.
    Hu Y; Houk KN; Kikuchi K; Hotta K; Hilvert D
    J Am Chem Soc; 2004 Jul; 126(26):8197-205. PubMed ID: 15225061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positional ordering of reacting groups contributes significantly to the efficiency of proton transfer at an antibody active site.
    Seebeck FP; Hilvert D
    J Am Chem Soc; 2005 Feb; 127(4):1307-12. PubMed ID: 15669871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of biomimetic catalysts by molecular imprinting in synthetic polymers: the role of transition state stabilization.
    Wulff G; Liu J
    Acc Chem Res; 2012 Feb; 45(2):239-47. PubMed ID: 21967389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kinetic basis of a general method for the investigation of active site content of enzymes and catalytic antibodies: first-order behaviour under single-turnover and cycling conditions.
    Topham CM; Gul S; Resmini M; Sonkaria S; Gallacher G; Brocklehurst K
    J Theor Biol; 2000 May; 204(2):239-56. PubMed ID: 10887904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonspecific catalysis by protein surfaces.
    Kirby AJ; Hollfelder F; Tawfik DS
    Appl Biochem Biotechnol; 2000; 83(1-3):173-80; discussion 180-1, 297-313. PubMed ID: 10826958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Just a near attack conformer for catalysis (chorismate to prephenate rearrangements in water, antibody, enzymes, and their mutants).
    Hur S; Bruice TC
    J Am Chem Soc; 2003 Sep; 125(35):10540-2. PubMed ID: 12940735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical analysis of antibody catalysis.
    Hilvert D
    Annu Rev Biochem; 2000; 69():751-93. PubMed ID: 10966475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of hapten binding and catalytic determinants in a family of catalytic antibodies.
    Ulrich HD; Schultz PG
    J Mol Biol; 1998 Jan; 275(1):95-111. PubMed ID: 9451442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new strategy for the generation of catalytic antibodies.
    Shokat KM; Leumann CJ; Sugasawara R; Schultz PG
    Nature; 1989 Mar; 338(6212):269-71. PubMed ID: 2922053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between binding energy and catalysis in the evolution of a catalytic antibody.
    Ulrich HD; Mundorff E; Santarsiero BD; Driggers EM; Stevens RC; Schultz PG
    Nature; 1997 Sep; 389(6648):271-5. PubMed ID: 9305839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of ADP-ribosylating bacterial toxins based on oxacarbenium ion character at their transition states.
    Zhou GC; Parikh SL; Tyler PC; Evans GB; Furneaux RH; Zubkova OV; Benjes PA; Schramm VL
    J Am Chem Soc; 2004 May; 126(18):5690-8. PubMed ID: 15125661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermodynamic and structural basis for transition-state stabilization in antibody-catalyzed hydrolysis.
    Oda M; Ito N; Tsumuraya T; Suzuki K; Sakakura M; Fujii I
    J Mol Biol; 2007 May; 369(1):198-209. PubMed ID: 17428500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossreactivity, efficiency and catalytic specificity of an esterase-like antibody.
    Gigant B; Charbonnier JB; Eshhar Z; Green BS; Knossow M
    J Mol Biol; 1998 Dec; 284(3):741-50. PubMed ID: 9826512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody catalysis. The key is in the pocket.
    Benkovic SJ
    Nature; 1996 Sep; 383(6595):23-4. PubMed ID: 8779708
    [No Abstract]   [Full Text] [Related]  

  • 18. Transition-state stabilization as a measure of the efficiency of antibody catalysis.
    Stewart JD; Benkovic SJ
    Nature; 1995 Jun; 375(6530):388-91. PubMed ID: 7760931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in catalytic antibodies.
    Scanlon TS; Schultz PG
    Philos Trans R Soc Lond B Biol Sci; 1991 May; 332(1263):157-64. PubMed ID: 1678534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.